Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 15, 2020
CdSe quantum dots evaluation in primary cellular models or tissues derived from patients
Carlota Tosat-Bitrián, Valle Palomo
Pharmaceutics
|
February 2, 2021
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles
Elisa Rojas-Prats, Carlota Tosat-Bitrián, Loreto Martínez-González, et al.
Nanomaterials (Basel, Switzerland)
|
April 3, 2021
CdSe Quantum Dots in Human Models Derived from ALS Patients: Characterization, Nuclear Penetration Studies and Multiplexing
Carlota Tosat-Bitrián, Alicia Avis-Bodas, Gracia Porras, et al.
Frontiers in Molecular Neuroscience
|
August 25, 2023
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patients
Loreto Martinez-Gonzalez, Eva P Cuevas, Carlota Tosat-Bitrián, et al.
ACS Applied Materials & Interfaces
|
November 8, 2024
Membrane-Targeted Quantum Dot-Based BACE1 Activity Sensors for <i>In Vitro</i> and <i>In Cellulo</i> Assays
Carlota Tosat-Bitrián, Jesús Alejandro Bueso de Barrio, Michael H Stewart, et al.
Angewandte Chemie (International Ed. in English)
|
June 25, 2021
From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis
Vanesa Nozal, Alfonso García-Rubia, Eva P Cuevas, et al.
ACS Chemical Neuroscience
|
October 14, 2024
Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation
Carmen Pérez de la Lastra Aranda, Carlota Tosat-Bitrián, Gracia Porras, et al.
ACS Sensors
|
May 21, 2026
Lighting Up Mislocalized Proteins: Quantum Dot Probes for Multiplexed Cytoplasm-Selective Cell Profiling in Neurodegeneration
Paula Fernández-Gómez, Carlota Tosat-Bitrián, Tania Marugán, et al.
Neurobiology of Disease
|
February 7, 2024
Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis
Eva P Cuevas, Loreto Martinez-Gonzalez, Clara Gordillo, et al.
Frontiers in Bioengineering and Biotechnology
|
August 7, 2023
Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale
Paula Fernández-Gómez, Carmen Pérez de la Lastra Aranda, Carlota Tosat-Bitrián, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Nanomedicine : Nanotechnology, Biology, and Medicine
|
September 15, 2020
CdSe quantum dots evaluation in primary cellular models or tissues derived from patients
Carlota Tosat-Bitrián, Valle Palomo
Pharmaceutics
|
February 2, 2021
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles
Elisa Rojas-Prats, Carlota Tosat-Bitrián, Loreto Martínez-González, et al.
Nanomaterials (Basel, Switzerland)
|
April 3, 2021
CdSe Quantum Dots in Human Models Derived from ALS Patients: Characterization, Nuclear Penetration Studies and Multiplexing
Carlota Tosat-Bitrián, Alicia Avis-Bodas, Gracia Porras, et al.
Frontiers in Molecular Neuroscience
|
August 25, 2023
TTBK1 and CK1 inhibitors restore TDP-43 pathology and avoid disease propagation in lymphoblast from Alzheimer's disease patients
Loreto Martinez-Gonzalez, Eva P Cuevas, Carlota Tosat-Bitrián, et al.
ACS Applied Materials & Interfaces
|
November 8, 2024
Membrane-Targeted Quantum Dot-Based BACE1 Activity Sensors for <i>In Vitro</i> and <i>In Cellulo</i> Assays
Carlota Tosat-Bitrián, Jesús Alejandro Bueso de Barrio, Michael H Stewart, et al.
Angewandte Chemie (International Ed. in English)
|
June 25, 2021
From Kinase Inhibitors to Multitarget Ligands as Powerful Drug Leads for Alzheimer's Disease using Protein-Templated Synthesis
Vanesa Nozal, Alfonso García-Rubia, Eva P Cuevas, et al.
ACS Chemical Neuroscience
|
October 14, 2024
Proteome Aggregation in Cells Derived from Amyotrophic Lateral Sclerosis Patients for Personalized Drug Evaluation
Carmen Pérez de la Lastra Aranda, Carlota Tosat-Bitrián, Gracia Porras, et al.
ACS Sensors
|
May 21, 2026
Lighting Up Mislocalized Proteins: Quantum Dot Probes for Multiplexed Cytoplasm-Selective Cell Profiling in Neurodegeneration
Paula Fernández-Gómez, Carlota Tosat-Bitrián, Tania Marugán, et al.
Neurobiology of Disease
|
February 7, 2024
Casein kinase 1 inhibitor avoids TDP-43 pathology propagation in a patient-derived cellular model of amyotrophic lateral sclerosis
Eva P Cuevas, Loreto Martinez-Gonzalez, Clara Gordillo, et al.
Frontiers in Bioengineering and Biotechnology
|
August 7, 2023
Nanomedical research and development in Spain: improving the treatment of diseases from the nanoscale
Paula Fernández-Gómez, Carmen Pérez de la Lastra Aranda, Carlota Tosat-Bitrián, et al.
Page
of 2